Cargando…
Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas
Non-Hodgkin lymphoma (NHL) are a diverse group of hematological malignancies comprised of over 60 subtypes. These subtypes range from indolent to aggressive. The PI3K/Akt/mTOR pathway has been shown to contribute to cell survival and proliferation and is constitutively active in most NHL. MK-7075 (m...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253055/ https://www.ncbi.nlm.nih.gov/pubmed/34221985 http://dx.doi.org/10.3389/fonc.2021.670275 |